Categories
Connect with us on LinkedIn
Can AI actually help sites?
Most clinical trial sites still capture protocol data on paper. On July 1 at 1 PM EDT, Brad...
What nine years of MDR experience is changing about PMCF planning, and where AI fits in
Nine years into EU MDR, the conversation has moved past "how do we collect PMCF data" to a...
The 2027 RWE Playbook
Most RWE programs weren't built for 2027. They were built for 2019 — before FDA issued device-specific guidance...
The UAT window is days. The eCOA study runs months. Here’s how AI bridges that gap.
eCOA systems contain time-dependent logic that unfolds over months of a live study: compliance windows, adaptive triggers, missed-visit...
When the surgeon never touched the EDC: what the SAGES x Castor webinar covered
Surgical registry data entry runs 10 to 45 minutes per patient chart. That was the number Sangrag Ganguli,...
AI in eCOA: What Works. What Breaks
AI is being applied to eCOA localization, but most teams are still figuring out where it genuinely helps...
PMCF requirements are raising hard questions about cost, device viability, and where AI fits in
Most PMCF programs weren't designed for EU MDR. They were built before Article 61(11) made ongoing clinical data...
Trust LLMs with Chart Review: Validation Framework
Most AI chart review vendors oversell accuracy and ignore the pipeline problem entirely. This brief shows what peer-reviewed...
Where PRO strategy goes wrong: therapeutic area fit, capture frequency, and the implementation gap that takes years to surface
Expert insights on PRO data, regulatory uncertainty, and the implementation gap that kills most ePRO strategies. Watch the...
The eCOA Iceberg: uncovering the hidden costs of software-only models
SaaS eCOA looks cheaper on paper. This guide exposes five hidden costs that change the full-service vs. software-only...
The Temporal Conundrum: Bridging the Gap Between Manual UAT and AI Automation in eCOA
Manual eCOA UAT runs 12-16 weeks because time-dependent protocol logic must be tested across a study's full duration....
End the surgical data entry burden: AI-assisted, human-supervised, 80% faster
On May 6, 2026, Castor and SAGES are hosting a 30-minute session on ending the surgical data entry...
Leveraging the patient voice to reduce regulatory uncertainty during submission
Learn how PRO data closes evidence gaps in FDA and EMA submissions. Join outcomes expert Ari Gnanasakthy and...
Beyond the EHR: meeting the FDA’s new real-world evidence standards
The FDA’s December 2025 device guidance and March 2026 ICH M14 adoption raise the bar for RWE programs....
Biotech AI strategy for clinical teams | LinkedIn Live
LinkedIn Live event tile featuring Derk Arts, CEO of Castor, and Solomon Babani, Founder and CEO of Symbiosis...
The ePRO blueprint for pain trials: Optimizing data capture from protocol design to efficacy endpoints
The 11-point electronic Numeric Rating Scale (eNRS) is now the preferred digital standard for BYOD pain trials, recommended...
Early-stage biotech’s AI advantage is a window that closes. Sol Babani and Derk Arts on how to use it.
Sol Babani and Derk Arts on why early-stage biotech must build AI-native operations, not retrofit old ones. Decision...
Better Evidence Starts with Better Infrastructure
Meet Castor at ISPOR US 2026 | May 17-20 | Philadelphia, PA
Schedule a meeting with the Castor team at ISPOR US 2026. See Castor Catalyst AI for real-world evidence...
Connect with us on LinkedIn
